GB0511203D0 - Vaccines - Google Patents

Vaccines

Info

Publication number
GB0511203D0
GB0511203D0 GBGB0511203.2A GB0511203A GB0511203D0 GB 0511203 D0 GB0511203 D0 GB 0511203D0 GB 0511203 A GB0511203 A GB 0511203A GB 0511203 D0 GB0511203 D0 GB 0511203D0
Authority
GB
United Kingdom
Prior art keywords
vaccines
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0511203.2A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Birmingham
Original Assignee
University of Birmingham
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Birmingham filed Critical University of Birmingham
Priority to GBGB0511203.2A priority Critical patent/GB0511203D0/en
Publication of GB0511203D0 publication Critical patent/GB0511203D0/en
Priority to PCT/GB2006/001989 priority patent/WO2006129090A2/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/105—Delta proteobacteriales, e.g. Lawsonia; Epsilon proteobacteriales, e.g. campylobacter, helicobacter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0258—Escherichia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0275—Salmonella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
GBGB0511203.2A 2005-06-02 2005-06-02 Vaccines Ceased GB0511203D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB0511203.2A GB0511203D0 (en) 2005-06-02 2005-06-02 Vaccines
PCT/GB2006/001989 WO2006129090A2 (en) 2005-06-02 2006-06-02 Vaccines

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0511203.2A GB0511203D0 (en) 2005-06-02 2005-06-02 Vaccines

Publications (1)

Publication Number Publication Date
GB0511203D0 true GB0511203D0 (en) 2005-07-06

Family

ID=34834989

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0511203.2A Ceased GB0511203D0 (en) 2005-06-02 2005-06-02 Vaccines

Country Status (2)

Country Link
GB (1) GB0511203D0 (en)
WO (1) WO2006129090A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10842861B2 (en) * 2016-05-26 2020-11-24 Universiteit Gent Method of reducing egg contamination
CN110257312B (en) * 2019-05-06 2021-04-06 浙江工业大学 Recombinant gene engineering bacterium and application thereof in producing vanillin by fermentation

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0659086B1 (en) * 1992-09-04 1998-11-11 The University of Saskatchewan Novel bacterial vaccines using vaccine strains of pathogenic bacteria
US6346391B1 (en) * 1999-07-22 2002-02-12 Trustees Of Tufts College Methods of reducing microbial resistance to drugs
GB9923858D0 (en) * 1999-10-09 1999-12-08 Neutec Pharma Plc Antimicrobial compositions
DE10208175A1 (en) * 2002-02-20 2003-09-04 Medinnova Ges Med Innovationen Nucleotide sequence coding for a TolC and a defined amino acid sequence

Also Published As

Publication number Publication date
WO2006129090A3 (en) 2007-01-25
WO2006129090A2 (en) 2006-12-07

Similar Documents

Publication Publication Date Title
IL192084A0 (en) Vaccine
GB0504436D0 (en) Vaccine
GB0513421D0 (en) Vaccines
GB2434367B (en) Improved vaccines
IL178890A0 (en) Vaccines
GB0522765D0 (en) Combination vaccine manufacture
GB0616306D0 (en) Vaccines
GB0420634D0 (en) Vaccines
GB0524409D0 (en) Vaccines
GB0524408D0 (en) Vaccines
GB0515135D0 (en) Vaccine
ZA200709207B (en) Vaccine
GB0614460D0 (en) Vaccines
GB0516944D0 (en) Vaccine
GB0413510D0 (en) Vaccine
GB0810662D0 (en) Vaccine
GB0511203D0 (en) Vaccines
ZA200709210B (en) Vaccine
GB0526412D0 (en) Vaccine
GB0524407D0 (en) Vaccines
GB0510280D0 (en) Vaccines
GB0513191D0 (en) Vaccine
GB0509010D0 (en) Vaccine
IL186586A0 (en) Vaccine
GB0526232D0 (en) Vaccine

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)